DAG Ventures Management V, LLC

DAG Ventures Management V, LLC discloses dealings in 2 companies, chiefly ARMO BioSciences, Inc. and Atara Biotherapeutics, Inc. The record holds 12 filings, for trades running from 21 October 2014 to 30 January 2018.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 30 January 2018, the filings show a transaction in ARMO BioSciences, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.